|
|
|
|
LEADER |
01658nam a2200289 u 4500 |
001 |
EB000943438 |
003 |
EBX01000000000000000737028 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
150223 r ||| eng |
245 |
0 |
0 |
|a The diagnosis and treatment of lung cancer (update)
|h Elektronische Ressource
|c developed for NICE by the National Collaborating Centre for Cancer
|
260 |
|
|
|a Cardiff, UK
|b National Collaborating Centre for Cancer (UK)
|c 2011, 2011
|
300 |
|
|
|a 1 PDF file (xix, 178 p.)
|b ill
|
505 |
0 |
|
|a Includes bibliographical references
|
653 |
|
|
|a United Kingdom
|
653 |
|
|
|a Carcinoma, Non-Small-Cell Lung
|
653 |
|
|
|a Small Cell Lung Carcinoma
|
710 |
2 |
|
|a National Collaborating Centre for Cancer (Great Britain)
|
710 |
2 |
|
|a National Institute for Health and Clinical Excellence (Great Britain)
|
740 |
0 |
2 |
|a Lung cancer
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
490 |
0 |
|
|a NICE clinical guidelines
|
500 |
|
|
|a "April 2011."
|
856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK99021
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
082 |
0 |
|
|a 610
|
520 |
|
|
|a This guidance updates and replaces NICE clinical guideline 24 (published February 2005). New and updated recommendations are included on communication, diagnosis and staging, selection of patients with non-small-cell lung cancer (NSCLC) for treatment with curative intent, surgical techniques, smoking cessation, combination treatment for NSCLC, treatment of small-cell lung cancer (SCLC), managing endobronchial obstruction, managing brain metastases and follow-up and patient perspectives
|